VERADIGM INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2015-11-30: Form 8-K; Period of report 2015-11-30; Description 8.01 Other Events; Details 8.01.
- 2015-11-05: Form 8-K; Period of report 2015-11-05; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2015-10-07: Form 8-K; Period of report 2015-10-01; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure; Details 5.02.
- 2015-10-02: Form 8-K; Period of report 2015-09-30; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2015-11-30 | 8-K | 2015-11-30 | 8.01 Other Events | 8.01 On November 30, 2015, Allscripts Healthcare Solutions, Inc. (the "Company") issued a press release which announced that its Board of Directors has authorized a share repurchase program to permit the Company to repurchase up to $150 million of its outstanding common shares through December 31, 2018. | document.htm |
| 2015-11-05 | 8-K | 2015-11-05 | 2.02 Results of Operations and Financial Condition | 2.02 On November 5, 2015, Allscripts Healthcare Solutions, Inc. (the "Company") issued a press release regarding the Company's financial results for the three and nine months ended September 30, 2015. | document.htm |
| 2015-10-07 | 8-K | 2015-10-01 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure | 5.02 On October 1, 2015, the Board of Directors of Allscripts Healthcare Solutions, Inc. (the “Company”) appointed Richard J. Poulton, age 50, the Company’s Executive Vice President and Chief Financial Officer, as its President. 7.01 On October 7, 2015, the Company issued a press release announcing Mr. Poulton’s promotion to President of the Company. | mdrx-8k_20151001.htm |
| 2015-10-02 | 8-K | 2015-09-30 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 On September 30, 2015, Allscripts Healthcare Solutions, Inc. (the “Company”) and Allscripts Healthcare, LLC (“Allscripts Healthcare”) entered into a Replacement Facility Amendment the (“Replacement Facility Amendment”) to the Credit Agreement, dated as of June 28, 2013, as amended on June 8, 2015 (the “Existing Credit Agreement”, and, as amended by the Replacement Facility Amendment, the “Amended Credit Agreement”), with JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”), the several banks and other financial institutions or entities from time to time party thereto, and Fifth Third Bank, KeyBank National Association and SunTrust Bank, as syndication agents. 2.03 The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03. | mdrx-8k_20150930.htm |
| 2015-08-20 | 8-K | 2015-08-18 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 On August 18, 2015, the Board of Directors of Allscripts Healthcare Solutions, Inc. (the “Company”) approved an amendment to the Company’s Amended and Restated By-Laws, effective the same date, to add a new Article IX thereto providing that, unless the Board, on behalf of the Company, consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another state court located within the State of Delaware or, if no court located within the State of Delaware has jurisdiction, the federal district court for the District of Delaware) will be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Company to the Company or the Company’s stockholders, (iii) any action asserting a claim against the Company or any of its directors, officers or other employees arising pursuant to any provision of the Delaware General Corporation Law, the Company’s Certificate of Incorporation or the By-Laws (in each case, as may be amended from time to time) or (iv) any action asserting a claim against the Company or any of its directors, officers or other employees governed by the internal affairs doctrine of the State of Delaware, in all cases subject to the court’s having personal jurisdiction over all indispensable parties named as defendants. | mdrx-8k_20150818.htm |
| 2015-08-04 | 8-K | 2015-07-30 | 2.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 2.02 On August 4, 2015, Allscripts Healthcare Solutions, Inc. (the "Company") issued a press release regarding the Company's financial results for the three and six months ended June 30, 2015. 5.02 On July 30, 2015, Mr. Greg Garrison was appointed to the Board of Directors of the Company, to hold office until the next annual meeting of stockholders. | document.htm |
| 2015-07-16 | 8-K | 2015-07-16 | 2.02 Results of Operations and Financial Condition | 2.02 On July 16, 2015, Allscripts Healthcare Solutions, Inc. (the "Company") issued a press release regarding the Company's preliminary financial results for the second quarter ended June 30, 2015. | document.htm |
| 2015-06-30 | 8-K | 2015-06-26 | 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure; 8.01 Other Events | 3.02 The disclosure set forth in Item 8.01 of this Current Report on Form 8-K (other than the disclosure under the caption “Investment in NantHealth”) is incorporated into this Item 3.02 by reference. 7.01 On June 30, 2015, Allscripts Healthcare Solutions, Inc. (the “Company”) issued a press release announcing the closing of the Private Placement (as defined below) and the Investment (as defined below). 8.01 On June 26, 2015, the Company entered into certain agreements with Nant Health, LLC (“NantHealth”) and an affiliate thereof, including that certain Securities Purchase Agreement, dated June 26, 2015 (the “SPA”), by and between the Company and Nant Capital, LLC (the “Investor”), and that certain Series G Units Purchase Agreement, dated June 26, 2015 (“Series G Purchase Agreement”), by and between the Company and NantHealth. | mdrx-8k_20150626.htm |
| 2015-06-01 | 8-K | 2015-05-29 | 5.07 Submission of Matters to a Vote of Security Holders | d935736d8k.htm | |
| 2015-05-07 | 8-K | 2015-05-07 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 On May 7, 2015, Allscripts Healthcare Solutions, Inc. (the “Company”) issued a press release regarding the Company’s financial results for the three months ended March 31, 2015. 7.01 Attached hereto as Exhibit 99.2 is supplemental financial information, including information for historical periods relating to the Company’s revised presentation of revenue and the associated cost of revenue in its consolidated statement of operations. | f8k_050715.htm |
| 2015-02-26 | 8-K | 2015-02-26 | 2.02 Results of Operations and Financial Condition | 2.02 On February 26, 2015, Allscripts Healthcare Solutions, Inc. (the "Company") issued a press release regarding the Company's financial results for the three and twelve months ended December 31, 2014. | document.htm |
| 2015-01-26 | 8-K | 2015-01-22 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On January 22, 2015, Robert J. Cindrich, a member of the Board of Directors (the “Board”) of Allscripts Healthcare Solutions, Inc. (the “Company”), informed the Company that he will not stand for re-election when his term expires at the Company’s 2015 Annual Meeting of Stockholders. | d858252d8k.htm |